Baseline characteristics validate the inclusion criteria of a phase III comparison of toremifene and placebo for the prevention of prostate cancer in men with isolated high grade prostatic intraepithelial neoplasia (HGPIN)

被引：0
|
作者：
Taneja, S. S. [1 ]
机构：
[1] NYU, Sch Med, Dept Urol, New York, NY 10003 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1569-9056(08)60609-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
613
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of a double-blind, placebo controlled, phase IIB clinical trial
    Price, David
    Stein, Barry
    Sieber, Paul
    Tutrone, Ronald
    Bailen, James
    Goluboff, Erik
    Burzon, Daniel
    Bostwick, David
    Steiner, Mitchell
    [J]. JOURNAL OF UROLOGY, 2006, 176 (03): : 965 - 970
  • [2] Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia.
    Price, D
    Stein, B
    Goluboff, E
    Sieber, P
    Bostwick, D
    Barnette, G
    Boger, R
    Steiner, MS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 106S - 106S
  • [3] Obesity and high-grade prostatic intraepithelial neoplasia (HGPIN) or prostate cancer.
    Fowke, JH
    Motley, SS
    Browning, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2757S - 2758S
  • [4] Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison
    Cui, Kang
    Li, Xiangnan
    Du, Yabing
    Tang, Xiance
    Arai, Seiji
    Geng, Yiwei
    Xi, Ying
    Xu, Han
    Zhou, Yue
    Ma, Wang
    Zhang, Tengfei
    [J]. ONCOTARGET, 2017, 8 (22) : 36674 - 36684
  • [5] Biomarkers for the Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)
    De Torres, Ines
    Sequeiros, Tamara
    Landolfi, Stefania
    Maria Bastaros, Juan
    Rigau, Marina
    Planos, Jacques
    Olivan, Mireia
    Ramon y Cajal, Santiago
    Morote, Juan
    Doll, Andreas
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 215A - 215A
  • [6] Biomarkers for the Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)
    De Torres, Ines
    Sequeiros, Tamara
    Landolfi, Stefania
    Bastaros, Juan Maria
    Rigau, Marina
    Planos, Jacques
    Olivan, Mirela
    Ramon y Cajal, Santiago
    Morote, Juan
    Doll, Andreas
    [J]. MODERN PATHOLOGY, 2015, 28 : 215A - 215A
  • [7] Evaluation of Erg Expression in Isolated High Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Benign Prostate Glands
    Stall, J. N.
    Palanisamy, N.
    Siddiqui, J.
    Chinnaiyan, A. M.
    Tomlins, S. A.
    Kunju, L. P.
    [J]. MODERN PATHOLOGY, 2012, 25 : 242A - 242A
  • [8] Evaluation of Erg Expression in Isolated High Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Benign Prostate Glands
    Stall, J. N.
    Palanisamy, N.
    Siddiqui, J.
    Chinnaiyan, A. M.
    Tomlins, S. A.
    Kunju, L. P.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 242A - 242A
  • [9] Men with high-grade prostatic intraepithelial neoplasia (HGPIN) remain at high risk for prostate cancer regardless of whether HGPIN is detected on subsequent biopsies
    Burzon, D
    Kahnoski, RJ
    Bennett, JK
    Barnette, KG
    Steiner, MS
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 184 - 184
  • [10] Toremifene for the prevention of prostate cancer among 514 men with high-grade prostatic intraepithelial neoplasia (PIN): Results of a double-blind, placebo-controlled phase IIB trial
    Price, D
    Stein, B
    Goluboff, E
    Sieber, P
    Bostwick, D
    Barnette, KG
    Steiner, MS
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 188 - 189
12345